Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,544,900
-
Total 13F shares
-
3,440,451
-
Share change
-
+2,835,504
-
Total reported value
-
$17,167,063
-
Price per share
-
$4.99
-
Number of holders
-
50
-
Value change
-
+$13,438,431
-
Number of buys
-
42
-
Number of sells
-
9
Institutional Holders of FibroBiologics, Inc. - Common Stock (FBLG) as of Q2 2024
As of 30 Jun 2024,
FibroBiologics, Inc. - Common Stock (FBLG) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,440,451 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Cascade Financial Partners, LLC, VANGUARD GROUP INC, Transform Wealth, LLC, Optivise Advisory Services LLC, Requisite Capital Management, LLC, American Institute for Advanced Investment Management, LLP, and BANK OF AMERICA CORP /DE/.
This page lists
50
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.